RxDoctor Payments Data

Nicole Zuber

Child & Adolescent Psychiatry · Newark, NJNPI 1407017932

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 196 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 15 manufacturers reported payments, led by Alkermes, Inc. at 25.1% of the total. 2025 is the largest year on record at $925, more than ten times the $30 reported in 2019.

$3,080in general payments, 2019–2025

Across 196 payments — averaging $15.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Alkermes, Inc.$772
  • Johnson & Johnson$653
  • Lundbeck LLC$354
  • Teva Pharmaceuticals USA, Inc.$284
  • Neurocrine Biosciences, Inc.$252
  • Supernus Pharmaceuticals, Inc.$216
  • plus $550 from 9 others

What the payments were for

  • Food & beverage$3,080100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,080 in reported general payments places this provider in the 85th percentile of 137 child & adolescent psychiatry providers in New Jersey.

See all child & adolescent psychiatry providers in New Jersey

Other child & adolescent psychiatry in Newark

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →